Osta Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Osta Therapeutics General Information

Description

Developer of novel antibiotic molecules designed to combat antibiotic resistance through targeted molecular engineering. The company's platform provides pathogen-specific activity, broad-spectrum antibacterial coverage, and sustained efficacy without inducing resistance, enabling healthcare providers to treat infections while minimizing impact on beneficial bacteria.

Contact Information

Website
www.ostatx.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 63, rue André Bollier
  • 69007 Lyon
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 63, rue André Bollier
  • 69007 Lyon
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Osta Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 20-Sep-2024 Completed Startup
To view Osta Therapeutics’s complete valuation and funding history, request access »

Osta Therapeutics Patents

Osta Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3134712-B1 Prodrogue intended for the treatment of bacterial infections resistant to beta-lactam antibiotics Active 22-Apr-2022
EP-4511037-A1 Prodrug intended for the treatment of bacterial infections resistant to antibiotics of the beta-lactam family Pending 22-Apr-2022
FR-3134712-A1 Prodrug intended for the treatment of bacterial infections resistant to antibiotics of the beta-lactam family Active 22-Apr-2022
WO-2023203187-A1 Prodrug intended for the treatment of bacterial infections resistant to antibiotics of the beta-lactam family Inactive 22-Apr-2022 A61K31/546

Osta Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Osta Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pulsalys Accelerator/Incubator
To view Osta Therapeutics’s complete investors history, request access »

Osta Therapeutics FAQs

  • When was Osta Therapeutics founded?

    Osta Therapeutics was founded in 2022.

  • Where is Osta Therapeutics headquartered?

    Osta Therapeutics is headquartered in Lyon, France.

  • What is the size of Osta Therapeutics?

    Osta Therapeutics has 4 total employees.

  • What industry is Osta Therapeutics in?

    Osta Therapeutics’s primary industry is Drug Discovery.

  • Is Osta Therapeutics a private or public company?

    Osta Therapeutics is a Private company.

  • What is Osta Therapeutics’s current revenue?

    The current revenue for Osta Therapeutics is .

  • Who are Osta Therapeutics’s investors?

    Pulsalys has invested in Osta Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process